New US Population Study Projects Steep Rise in Cardiovascular Diseases by 2060
Study projects substantial changes in the prevalence of CV risk factors and disease in the U.S. population by 2060, with an increasing prevalence among Black and Hispanic populations who have historically experienced poor access to quality health care. Targeted efforts toward improved screening and equitable access to quality health care in populations with the greatest growth in CV risk factors or disease would be expected to have a substantial impact to reduce future CV risk for the population overall. |
|
Non-Invasive FFR Gets Boost from Medtronic
FFRangio was developed by CathWorks, an Israeli company, and was approved by the US FDA in 2018. The pivotal study that led to FDA approval, FAST-FFR, showed that angiography-derived FFR was highly accurate when compared with pressure-wire FFR.
This week Medtronic announced that it was investing $75 million in the company, co-promoting its use, and has an option to acquire CathWorks for $585 million, once certain milestones are met. |
Significantly Improved Results for Medtronic's Evolut TAVR seen in the Optimize PRO Study
At this year's EuroPCR meeting, the interim results of the Optimize PRO study of Medtronic's Evolut™ PRO and PRO+ TAVR systems in 400 patients were presented as a Hotline Trial: permanent pacemaker rates dropped to single digits (9.2%) and the number of patients with moderate or severe paravalvular leak (PVL) was zero (78% of patients had no or only trace PVL). Moreover, the median length of hospital stay was one day. |
Emergency: Climate Crisis!
The Lancet, along with over 220 medical journals, today posted an editorial about the largest, most serious, health threat known to us today. It's not heart disease, or cancer, or COVID-19. It's climate change! And it can't be cured by angioplasty or surgery or chemo. In the words of Dr. Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization, "The COVID-19 pandemic will end, but there is no vaccine for the climate crisis." |
FDA OK to Philips Azurion SmartCT Imaging Software
SmartCT is a key component of Philips Azurion Image Guided Therapy System, providing interventionalists with CT-like 3D images (Cone Beam CT) to support diagnosis, therapy planning, treatment and follow-up for interventional procedures. |
*COVID-19* Cardiac Arrest Deaths at Home in NYC
Have Increased By a Startling 800%
There's been a 50% or more drop in the number of people receiving emergency treatment for heart attacks in many hospitals. Physicians have been speculating why this might be. Now frightening numbers from New York City's overwhelmed emergency medical system may provide part of the answer: hundreds of people a day have been dying of cardiac arrest in their homes, an eight-fold increase over the same period last year. |
*COVID-19* Doctors Say: Don't Sit Out a Heart Attack at Home
Since the onset of the novel coronavirus COVID-19, hospital emergency departments have seen a precipitous drop in the number of heart attack patients presenting for treatment. Not getting treated means heart muscle dies. What should patients do? |
|
|
|
| Patients Are Talking About... |
- I had radial angiography 2 days ago...it was a fascinating experience and was able to watch part of the procedure. I feel fantastic, have no "heart ache" or any problems with my arm.
- I can't afford my post-stenting meds, where can I find help paying for Plavix or Effient?
- I'm 64. After 4 stents and 2 heart attacks since Dec. 2008, I'm as physically active or more so than ever. I plan to hit 4,000 miles on my bike this year. I've hiked/climbed at 13,000 feet.
|
| Patients
Are Reading About... |
Radial Hospital Locator
A list of physicians and hospitals offering the transradial (wrist) approach to angiograms, angioplasty and stent procedures. |
|
 |
| Read patient stories and Learn about medications after stenting, symptoms and complications, care giving, taking charge of your health, communicating with your cardiologist and much more in our Patient Center. |
 see
video clip:
" The 1st Angioplasty" |
ANGIOPLASTY
AT 40: 2017
marked the 40th anniversary of coronary angioplasty. In
1977 in Zurich, Switzerland, a young physician named Andreas
Gruentzig inserted a catheter into a patient's
coronary artery and inflated a tiny balloon, successfully
opening a blockage and restoring blood flow to a human
heart. |
| Today over
two million coronary angioplasties are
performed worldwide each year and angioplasty has become the gold standard for emergency heart attack treament. |
| What People Are Saying About Angioplasty.Org: |
| "Everyone,
please consider donating to this site, it is a wealth of
information and comfort. Where else can you get such great
information AND expedited? My dr's don't return phone calls
as quickly as I've gotten responses here!" --
Denise, Connecticut, USA |
| "Angioplasty.Org is awesome; I always refer patients to it. It makes a difference big time. They go and they look and see all the people interviewed and these well-known cardiologists around the world talking about it, and it takes that anxiety away." -- Sanjay Patel, MD, Houston, Texas, USA |
| "Thanks
to Angioplasty.Org for all the info which helped a lot
in my decision making and post procedure recovery." --
Muralidharan, Chennai, India |
| "Burt Cohen (Senior Editor of Angioplasty.Org) has been documentarian of this field of medicine for 30 years" -- Dr. Stephen Oesterle, SVP Medicine and Technology, Medtronic Corp. |
| "I
just want you to know that you probably saved [my husband's]
life by telling your story, and I want to thank you for
it." -- Marie, Canada |
|
|
Thank
You to Our Industry Grantmakers:
|
|
|
|
